UPDF AI

Review of gene therapies for age-related macular degeneration

A. Khanani,M. J. Thomas,6 Authors,P. Kaiser

2022 · DOI: 10.1038/s41433-021-01842-1
75 Citations

TLDR

The available data of current clinical trials for the treatment of neovascular and dry age-related macular degeneration with different AAV-based gene therapies are presented and current research on the progress of developing novel routes of administration for ocular gene therapies is presented.